Your browser doesn't support javascript.
loading
Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma.
Crombie, Jennifer L; Nastoupil, Loretta J; Redd, Robert; Tang, Kevin; Shouse, Geoffrey; Herrera, Alex F; Chow, Victor A; Shadman, Mazyar; Castaneda Puglianini, Omar; Saucier, Anna; Jacobson, Caron A; Armand, Philippe; Simmons, Gary.
Afiliação
  • Crombie JL; Dana-Farber Cancer Institute, Boston, MA.
  • Nastoupil LJ; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Redd R; Dana-Farber Cancer Institute, Boston, MA.
  • Tang K; Baylor School of Medicine, Houston, TX.
  • Shouse G; City of Hope Cancer Center, Duarte, CA.
  • Herrera AF; City of Hope Cancer Center, Duarte, CA.
  • Chow VA; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Alliance, Seattle, WA; and.
  • Shadman M; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Alliance, Seattle, WA; and.
  • Castaneda Puglianini O; Virginia Commonwealth University Medical Center, Richmond, VA.
  • Saucier A; Dana-Farber Cancer Institute, Boston, MA.
  • Jacobson CA; Dana-Farber Cancer Institute, Boston, MA.
  • Armand P; Dana-Farber Cancer Institute, Boston, MA.
  • Simmons G; Virginia Commonwealth University Medical Center, Richmond, VA.
Blood Adv ; 5(18): 3563-3567, 2021 09 28.
Article em En | MEDLINE | ID: mdl-34474474

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma de Células B Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma de Células B Idioma: En Ano de publicação: 2021 Tipo de documento: Article